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Abstract
Vagus nerve stimulation (VNS) has been successfully performed in animals for the treatment of different experimental
models of inflammation. The anti-inflammatory effect of VNS involves the release of acetylcholine by vagus nerve efferent
fibers inhibiting pro-inflammatory cytokines (e.g. TNF-a) produced by macrophages. Moreover, it has recently been
demonstrated that splenic lymphocytic populations may also be involved. As anesthetics can modulate the inflammatory
response, the current study evaluated the effect of two different anesthetics, isoflurane and pentobarbital, on splenic
cellular and molecular parameters in a VNS rat model. Spleens were collected for the characterization of lymphocytes sub-
populations by flow cytometry and quantification of cytokines secretion after in vitro activation. Different results were
observed depending on the anesthetic used. The use of isoflurane displayed a non-specific effect of VNS characterized by a
decrease of most splenic lymphocytes sub-populations studied, and also led to a significantly lower TNF-a secretion by
splenocytes. However, the use of pentobarbital brought to light immune modifications in non-stimulated animals that were
not observed with isoflurane, and also revealed a specific effect of VNS, notably at the level of T lymphocytes’ activation.
These differences between the two anesthetics could be related to the anti-inflammatory properties of isoflurane. In
conclusion, pentobarbital is more adapted than isoflurane in the study of the anti-inflammatory effect of VNS on an
anesthetized rat model in that it allows more accurate monitoring of subtle immunomodulatory processes.
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Introduction
The vagus nerve plays an important role in the control of
inflammation and is the principal component of the ‘‘reflex control
arc of immunity’’ [1]. This arc is composed of sensory afferent
fibers of the vagus nerve which detect the presence of molecules
secreted when inflammation or infection occurs at the periphery.
These afferent fibers convey the information to the central nervous
system (CNS). In response, the efferent fibers of the vagus nerve
are activated to transmit the information and modulate the
peripheral immune response. Therefore, the vagus nerve has a
double action: informing the CNS of a peripheral inflammation
via its afferents, and modulating inflammation via its efferent fibers
[2,3].
Low-frequency vagus nerve stimulation (VNS) has been
successful for the treatment of different animal models of
inflammation such as septic shock, pancreatitis, ischaemia-
reperfusion, postoperative ileus, and arthritis (see Tracey for
review [1]). We have previously demonstrated a potential role for
VNS as a therapeutic strategy for the treatment of chronic
inflammatory bowel disease in a rat model of colitis [4]. The anti-
inflammatory effect of VNS is mediated by the activation of the
vagus nerve efferent fibers, which in turn activate the cholinergic
anti-inflammatory pathway. This pathway, discovered by Tracey’s
group [5], is complementary to the hypothalamic-pituitary-
adrenal axis, classically activated by vagus nerve afferents. Vagus
nerve efferent fibers release acetylcholine, which binds to
macrophages nicotinic receptors. This binding inhibits the
translocation of the transcription factor NF-kB into the nucleus
which leads to the inhibition of the secretion of pro-inflammatory
cytokines such as TNF-a.
However, other pathways implicating different immune cells
could also be activated by VNS. Recent studies have shown that
the spleen has a crucial role in the anti-inflammatory effect of the
vagus nerve [6,7,8]. In order to study the implication of the spleen
in the anti-inflammatory effect of VNS in the gut, we decided to
develop an anesthetized rat model. Indeed, the interest of working
on an anesthetized rat model was to study early molecular and
cellular mechanisms activated in response to VNS and inflamma-
tion, which is not possible when working on an implanted and
freely moving rat model. Nevertheless, as anesthetics may cause
interferences especially at the immunomodulatory level, the
evaluation of pitfalls inherent to the use of anesthetics seemed
important. The anti-inflammatory effect of VNS might be over- or
under-estimated depending on the anesthetic used.
Isoflurane is commonly used in studies where long-term
anesthesia is necessary because of different positive aspects: it is
easy to use, it causes low levels of stress for the induction of
anesthesia, its quality is readily monitored, and the dosage can be
easily modified according to the animal’s condition during the
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surgical intervention. However, isoflurane can potentially interfere
at different levels, such as the central nervous system [9,10] or the
immune system. Indeed, isoflurane has anti-inflammatory prop-
erties which can be sources of interferences in studies concerning
inflammation [11,12,13,14,15,16,17,18]. Moreover, the use of
isoflurane has not yet been studied in a VNS rat model.
On the other hand, pentobarbital is not known to have
immunoregulatory properties and is often used as control
anesthetic in studies concerning the effects of anesthetics on
inflammation [19,20,21,22]. However, pentobarbital is more
commonly used in short-term anesthesia because of its cardio-
pulmonary depressor properties and the difficulty of assessing
anesthesia depth. As VNS induces a small decrease in heart rate in
rats [23,24,25] and displays immunoregulatory properties, we
investigated the impact of two different anesthetics: isoflurane and
pentobarbital, to minimize the adverse effects of anesthesia in our
experimental model of VNS. For this purpose, our study focused
on molecular and cellular mechanisms occurring in the spleen in
response to the different anesthetics and VNS protocols.
Materials and Methods
Ethics Statement
All animals were treated according to guidelines approved by
the European legislation for the care of laboratory animals.
Protocols (ID#: 2009/21.0) were approved specifically for this
study by the IRBA Animal Care and Use Committee (IACUC).
Animals
Adult male Sprague-Dawley rats (260–280 g) (Janvier, Le
Genest St Isle, France) were housed in a controlled environment
(12 h light/dark cycles, 20–22uC) with food and water ad libitum.
Rats were allowed a minimum of 7 days to adapt to housing
conditions before any manipulation.
Anesthesia
Two experimental protocols of anesthesia were used: volatile
anesthesia with isoflurane (Abott, Rungis, France) and intraper-
itoneal injection of pentobarbital (Ceva Sante´ Animale, Libourne,
France).
Five experimental groups were used for each anesthesia
protocol, with 10 rats in each: (1) control group without surgery;
(2) VNS 3 hours: anesthetized, operated, and stimulated for 3
hours; (3) VNS 20 minutes: anesthetized, operated, and stimulated
for 20 minutes; (4) sham 3 hours: anesthetized, operated, and not
stimulated; (5) sham 20 minutes: anesthetized, operated, and not
stimulated.
Every vagus nerve stimulation or sham period was preceded and
followed by 30 minutes of resting time under anesthesia. The total
time of anesthesia was respectively 1 hour and 20 minutes for the
20 minutes stimulated groups and 4 hours for the 3 hours
stimulated groups.
Pentobarbital (intraperitoneale injection, 125 ml/100 g) anes-
thetized rats were placed on electric heating pads and allowed to
breathe room air spontaneously. Isoflurane anesthetized rats were
placed in an airtight chamber where 3.5% isoflurane in 3l/min
oxygen was delivered to initiate anesthesia. Rats were then placed
on electric heating pads and anesthesia was maintained at 2.5%
isoflurane in 1l/min oxygen. Body temperature was monitored
with a rectal probe and maintained at 37uC. Oxygen saturation
and heart rate were monitored during the total length of
anesthesia (including surgery).
Experiments were performed simultaneously on 3 rats per day
(one animal from the control group; one from the non stimulated
group, and one from the stimulated group).
Surgical Procedures and Vagus Nerve Stimulation
Parameters
VNS was performed as previously described [4]. An incision
was made over the ventral region of the neck. The left vagus nerve
and the carotid artery were individualized and the vagus nerve was
separated from the carotid artery. A bipolar electrode (Harvard
Apparatus, France) was gently placed on the vagus nerve and
connected to a stimulation chain: S88 stimulator, SIU5 isolation
unit, CCU1 constant current unit (Grass Technologies, Astro-
Med, RI, US). VNS was performed using biphasic pulses with the
following parameters: 0.5 mA, 5 Hz, 500 ms pulse width and cycle
of 30 seconds ON and 300 seconds OFF.
At the end of the experiment, rats were euthanized with an
intracardiac injection of pentobarbital (DolethalH, 200 mg/kg). A
laparotomy was performed and the spleen was collected.
Spleen Preparation for flow Cytometry Analysis
The spleen was placed in 10 ml of cold phosphate buffer saline
(PBS) supplemented with bovine serum albumin (BSA) 1%. The
spleen was placed on a strainer (100 mm) and ground to
mechanically dissociate the cells and obtain single-cell suspension.
Isolated cells were then diluted with 20 ml of hypotonic lysis buffer
(ammonium chloride), allowing the lysis of red blood cells. After
centrifugation, cells were washed with PBS and filtered on a
40 mm strainer. After a last wash with PBS, the cells were
resuspended in 10 ml of PBS-BSA 1% and counted using Trypan
blue in Malassez cell in order to determine the total number of
cells derived from one whole spleen.
Splenocytes were stained with fluorescent antibodies in order to
characterize the different lymphocyte sub-populations present in
the spleen. Each staining was performed on one million cells. Cells
were incubated for 45 min with a mix of antibodies and PBS BSA
1% at 4uC. For each staining, an isotypic control was done to
determine the positive threshold of antigens according to the
strategy of ‘‘Fluorescence Minus One–FMO’’ [26]. After incuba-
tion, cells were washed with PBS, centrifuged, and the superna-
tants were removed. Pelleted cells were resuspended with PBS and
Hoechst 33258 (Sigma, L’Isle D’Abeau, France) for viability
assessment.
The following antibodies coupled with fluorochromes were
used:
APC Mouse Anti-Rat CD3, FITC Mouse Anti-Rat CD8a, PE-
Cy5 Mouse Anti-Rat CD4, PE Mouse Anti-Rat CD25, PE Mouse
Anti-Rat CD45RA, FITC Mouse Anti-Rat CD161a, PE Mouse
Anti-Rat cd T-Cell Receptor, PerCP Mouse Anti-Rat ab T-Cell
Receptor (BD Biosciences, Le Pont de Claix, France).
The analyses were performed on a FACS LSRII (BD
Biosciences). FACS data were interpreted using Flowjo software
(Tree Star, Ashland, USA). On the basis of the percentage
measured and the total cell numeration, an absolute number of
each sub-population per organ was calculated.
Quantification of Cytokines
One million unstained splenocytes from the single-cell suspen-
sion were placed in cell culture plates (96-well) coated with anti-
CD3 antibody (Abd Serotec, Oxford, UK) for 48 hours. Wells
were then washed with PBS and filled with one million cells with
soluble anti-CD28 (Abd Serotec, Oxford, UK), RPMI and foetal
calf serum (FCS) 10%. Plates were placed at 37uC, 5% CO2 for 48
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hours. Supernatants were collected and stored at 280uC before
cytokine quantification. To quantify cytokine secretion, Cytomet-
ric Beads Array (CBA) Rat Soluble Protein Flex Sets (BD
Biosciences) were used according to the manufacturer’s instruc-
tions. The quantified cytokines were the following: IL-4, TNF-a,
IL-1a, IFN-c, IL-10 and IL-6.
Statistical Analysis
Statistical analyses were performed on GraphPad Prism
software version 5.00 (GraphPad Software, San Diego, USA).
Data were analyzed with the non-parametric test Mann-Whitney
to evaluate differences between two groups. A p value of less than
0.05 was considered as statistically significant.
Results
The functionality of the vagus nerve was monitored by
recording the electrocardiogram of each animal, during the whole
experiment. A non-significant (mean 6 SEM 665%) decrease of
the heart rate was observed during the ON VNS period; the heart
rate went back to normal during the OFF period. This effect was
observed even after 3 hours of VNS, demonstrating that the vagus
nerve was not altered after long term VNS (data not shown).
Splenic lymphocyte sub-populations isolated from anesthetized
rats with isoflurane or pentobarbital were analyzed by flow
cytometry to evaluate the impact of both anesthetics on our
experimental VNS model. Different results were observed
depending on the anesthetic used. Firstly, we compared the effect
of the two anesthetics on sham groups in order to highlight their
effect on cellular parameters at basal level. Secondly, we evaluated
how these anesthetics may interfere with the anti-inflammatory
effect of VNS.
1- Effect of Pentobarbital and Isoflurane on Sham
Operated Animals
Flow cytometry results on splenocytes isolated from pentobar-
bital anesthetized rats showed a significant decrease of the number
of T lymphocytes (227%, p,0.05) (figure 1) and CD4 T
lymphocytes (229%, p,0.05) (figure 2) for all the operated
groups (sham 3 h and VNS 3 h groups) compared to the control
group (not operated). These variations in the number of T cells
could reflect an early inflammatory response induced by the
surgery used to place the stimulation electrode. A significant
increase (+27%, p,0.01) in lymphocytes activation was also
observed for the sham 3 h group compared to the control group
(figure 3). However, on rats anesthetized with isoflurane, there was
no significant effect on splenocytes from the sham 3 h group
compared to the control group for total cellularity (figure 4) and
for every sub-population studied (figures 1,2,3,5,6). Moreover,
when comparing the effect of both anesthetics (isoflurane versus
pentobarbital) on sham 3 h groups, a significant difference was
observed for the T CD4 lymphocytes sub-population (figure 2) and
for lymphocytes activation (figure 3). No difference was observed
between the two anesthetics on sham 20 min groups (data not
shown).
2-Interactions between the Type of Anesthetics and VNS
Data of rats anesthetized with isoflurane showed a modulation
in the number of cells. A significant decrease (225%, p,0.05) of
total spleen cellularity was observed for the VNS 3 h group
compared to the sham 3 h and control group (figure 4). This
significant decrease for the VNS 3 h group was also found for
other cellular sub-types such as total lymphocytes (224%, p,0.05)
(figure 5), T lymphocytes (226%, p,0.05) (figure 1), T CD4
lymphocytes (226%, p,0.05) (figure 2), activated T CD4
lymphocytes (227%, p,0.05) (CD25+) (figure 6). Moreover, a
non significant decrease was observed for the VNS 3 h group
compared to the sham 3 h group for T CD8 lymphocytes, B
lymphocytes and NK cells (data not shown).
Different results were obtained from splenocytes isolated from
rats anesthetized with pentobarbital. No decrease of the total
splenic cellularity was observed for splenocytes of the pentobar-
bital treated rats, unlike those of the isoflurane anesthetized rats
(figure 4). However, a decrease in lymphocytes activation (214%,
p,0.05) was observed for the 3 h VNS group compared to the
sham group (figure 3). The anti-inflammatory effect of VNS could
inhibit CD4 lymphocytes activation. Moreover, a significant
difference was observed between both VNS 3 h groups (isoflurane
versus pentobarbital) concerning lymphocytes activation (figure 3).
Figure 1. Quantification of splenic T CD3 for isoflurane and
pentobarbital anesthetized rats. The number of splenic T CD3
lymphocytes isolated from rats anesthetized with isoflurane or
pentobarbital was analysed with flow cytometry in the different groups
(control, sham 3 h, VNS 3 h). n = 10 rats per groups. *: p,0.05. A
significant decrease was observed for the VNS 3 h group compared to
the sham 3 h group for the isoflurane anesthetized rats. A significant
decrease of the number of splenic T CD3 lymphocytes was observed for
the operated groups (sham 3 h, VNS 3 h) compared to the control
group for the pentobarbital anesthetized rats (p,0.05).
doi:10.1371/journal.pone.0067086.g001
Figure 2. Quantification of splenic T CD4 for isoflurane and
pentobarbital anesthetized rats. The number of splenic T CD4
lymphocytes isolated from rats anesthetized with isoflurane or
pentobarbital was analysed with flow cytometry in the different groups
(control, sham 3 h, VNS 3 h). n = 10 rats per groups. *: p,0.05. A
significant decrease was observed for the VNS 3 h group compared to
the sham 3 h group for the isoflurane anesthetized rats. A significant
decrease was also observed for the operated groups (sham 3 h, VNS
3 h) compared to the control group for the pentobarbital anesthetized
rats. Moreover, a significant decrease was observed between both sham
3 h groups (pentobarbital versus isoflurane).
doi:10.1371/journal.pone.0067086.g002
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However, no effect was seen for the 20 min VNS and sham groups
(data not shown).
3-Cytokines Secreted by Cultured Splenocytes
A quantification of secreted cytokines was carried out in the
supernatants of cultured splenocytes. IL-6 and IL-1a were
considered as not detectable. IL-4, IL-10 and IFN-c were
detectable but no significant difference was observed between
activated splenocytes derived from isoflurane and pentobarbital
anesthetized animals (data not shown). However, important level
differences were observed for the secretion of the pro-inflamma-
tory cytokine TNF-a. The secretion level of TNF-a was
significantly lower (2 to 3 times, p,0.001) for all the experimental
groups anesthetized with isoflurane compared to the groups
anesthetized with pentobarbital (figure 7). The use of isoflurane
inhibits TNF-a secretion by cultured and activated splenocytes.
Discussion
In this study we evaluated the impact of two different
anesthetics on splenic cellular and molecular parameters to
minimize their potential adverse effects in our VNS model. We
have previously shown that low-frequency VNS (5 Hz), chroni-
cally performed in non-anesthetized animals, has anti-inflamma-
tory properties in a model of experimental colitis in rats [4].
Different pathways seem to be implicated in this anti-inflamma-
tory effect: the cholinergic anti-inflammatory pathway involving
macrophages, described in 2000 by Tracey’s group [5], and an
additional pathway implicating other immune cells. Recent data
have shown a crucial role of the spleen in the peripheral anti-
inflammatory effect of VNS [7]. In order to study the involvement
of the spleen in the anti-inflammatory effect of VNS, we decided to
develop an anesthetized rat model. However, given that anesthet-
ics may cause bias, it seemed important to previously evaluate the
pitfalls inherent to the use of an anesthetic for an immune-
modulation model. Different studies have shown that isoflurane
may have anti-inflammatory properties in different models
[19,22,27,28]; whereas pentobarbital has been shown to have
cardio-pulmonary depressor properties but no anti-inflammatory
effect has been detected until now. To be sure to use the most
relevant anesthetic for our experimental VNS model, we
performed a comparative study of isoflurane and pentobarbital
on our model. For this purpose, rats were either anesthetized with
an inhalation of isoflurane or with an intraperitoneal injection of
pentobarbital.
For the VNS and sham 20 min groups anesthetized for a total
time of 1 h20 min no significant results were observed. The
immunomodulatory effect of isoflurane might be observable only
after a greater delay between anesthesia and tissue collection.
Hofstetter et al. have demonstrated that a 50 seconds exposure of
isoflurane as a pretreatment before 4 hours of pentobarbital-
fentanyl anesthesia in an endotoxemic rat model allowed a
significant decrease of plasma levels of TNF-a and IL-1b [22]. We
hypothesized that immunomodulatory effects of isoflurane may
not be observable shortly after the beginning of anesthesia but only
after the onset of non-immediate molecular and cellular mecha-
nisms.
Figure 3. Splenic T CD4 activation for isoflurane and pento-
barbital anesthetized rats. The splenic T CD4 activation (percentage
of CD25+/CD4 LT) was analysed with flow cytometry for the different
conditions (control, sham 3 h, VNS 3 h) with either isoflurane or
pentobarbital anesthesia. n = 10 rats per groups. *: p,0.05, **: p,0.01.
Modulations of T CD4 activation were observed with pentobarbital but
not with isoflurane. A significant increase was observed for the sham
3 h group compared to the control group, as well as a significant
decrease for the VNS 3 h group compared to the sham 3 h group.
Moreover, a significant increase was observed for both VNS and sham
3 h groups from the pentobarbital anesthetized animals compared to
isoflurane anesthetized groups.
doi:10.1371/journal.pone.0067086.g003
Figure 4. Modulation of total splenic cellularity for isoflurane
and pentobarbital anesthetized rats. The total splenic cellularity
from rats anesthetized with isoflurane or pentobarbital was determined
using counting with Trypan blue in Malassez cell for the different
groups (control, sham 3 h, VNS 3 h). n = 10 rats per groups. *: p,0.05. A
significant decrease was observed for the VNS 3 h group compared to
the sham 3 h and control groups (p,0.05) for the isoflurane
anesthetized rats. In contrast, no significant effect was observed for
the pentobarbital anesthetized rats.
doi:10.1371/journal.pone.0067086.g004
Figure 5. Quantification of total lymphocytes for isoflurane
and pentobarbital anesthetized rats. The number of total splenic
lymphocytes isolated from rats anesthetized with isoflurane or
pentobarbital was analysed with flow cytometry in the different groups
(control, sham 3 h, VNS 3 h). n = 10 rats per groups. *: p,0.05. A
significant decrease was observed for the VNS 3 h group compared to
the sham 3 h group for the isoflurane anesthetized rats. No significant
effect was observed for the pentobarbital anesthetized rats.
doi:10.1371/journal.pone.0067086.g005
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For the VNS and sham 3 h groups anesthetized for 4 hours,
three different effects were observed. Firstly, concerning splenic
cellularity, the use of isoflurane brought to light a significant
decrease for the VNS group compared to the sham group for total
lymphocytes and all the other lymphocytes sub-populations. These
results showed that VNS did not have a significant effect on a
particular subtype of lymphocyte population but had a global
effect on all the different sub-populations. Even if this VNS effect
appears as non specific, it draws out an effect of VNS on cell
trafficking that may modulate a potential immune response. This
was not observed with pentobarbital which revealed other
modulations not observable with isoflurane. Indeed, a significant
decrease of the number of T lymphocytes was observed for all the
operated groups compared to the control group (non-operated).
This result was also observed for the number of T CD4
lymphocytes (significant for the 3 h groups and a trend for the
20 min groups). It was not the case for the other subpopulations.
This decrease of T lymphocytes for the different operated groups
compared to the control group could be the result of a small
inflammation caused by the surgery performed to place the
stimulation electrode on the vagus nerve. T lymphocytes could
leave the spleen to migrate to the site of inflammation.
Consequently, the use of pentobarbital allows us to highlight
precise variations of cellularity in the spleen and to monitor
dynamic cellular processes.
Secondly, significant modulations of T CD4 lymphocytes’
activation were observed with the use of pentobarbital but not
with isoflurane. A significant increase of the percentage of CD25+
cells in the CD4+ lymphocyte population was observed for the
sham 3 h group compared to the control group. This increase
could also be explained by a slight inflammation and a potential
cellular response in lymphoid organs due to the effect of the
surgical procedure to implant the stimulation electrode. Moreover,
a significant decrease of T CD4 activation for the VNS 3 h group
compared to the sham 3 h group was observed. VNS potentially
has an action on lymphocytes’ activation and expression of
receptors involved in the inflammatory response (CD25=a chain
of IL-2 receptor). In our model, variations of lymphocytes’
activation showing VNS anti-inflammatory effect were only seen
with the use of pentobarbital.
Finally, a significant effect was observed at the level of TNF-a
secretion by cultured and CD3/CD28 activated splenic lympho-
cytes. Even though the secretion levels of IFN-c and IL-10 were
comparable according to the anesthetic used, TNF-a secretion was
significantly lower for the isoflurane anesthetised groups compared
to pentobarbital anesthetised groups. This difference shows that
the anesthetics have no effect on lymphocytes’ activation in vitro;
however, the use of isoflurane significantly impacts the secretion
level of a specific cytokine, TNF-a. We hypothesize that isoflurane
inhibits TNF-a secretion via the NF-kB pathway as described
previously [13]. Other pathways may not be inhibited like the c-
jun/AP-1 pathway implicated in the IFN-c secretion [29,30].
On a rat model without inflammation, pentobarbital anesthesia
produced specific modulations at the cellular dynamic level,
lymphocytes’ activation, and TNF-a secretion unlike isoflurane
anesthesia, which caused a global modulation on every lympho-
cyte sub-population studied. These different processes are crucial
for the understanding of VNS effect that could be hidden by the
use of isoflurane. Significant differences were observed between
both sham 3 h groups (isoflurane versus pentobarbital) for the
number of T CD4 lymphocytes and lymphocytes’ activation. This
was also the case for both VNS 3 h groups (isoflurane versus
pentobarbital) at the level of lymphocytes’ activation. Our data
confirms the different effects that the two anesthetics have on our
experimental model. These differences could be explained by the
anti-inflammatory properties [19,22,27,28] of isoflurane, whereas
pentobarbital is not known to act on the inflammation process,
and is commonly used as a control anesthetic in studies on
anesthetic’s effects on inflammation [19,20,22,31]. Moreover,
isoflurane inhibits the NF-kB pathway which plays a key role in
the anti-inflammatory effect of VNS [18,32].
Although the use of isoflurane is more appropriate for long-term
anesthesia, it is not the suitable anesthetic to study the anti-
inflammatory effect of VNS in our model. Even if pentobarbital is
more complex to use, it appears to be more appropriate to
evaluate precise cellular responses implicated in the immunomod-
ulation process of VNS. In conclusion, on the basis of these results,
the choice of anesthetic must be carefully adapted to the
experimental model, particularly in animal models of immunoin-
flammatory disorders.
Figure 6. Quantification of splenic T CD4 CD25 lymphocytes
for isoflurane and pentobarbital anesthetized rats. The number
of splenic T CD4 CD25 lymphocytes isolated from rats anesthetized with
isoflurane or pentobarbital was analysed with flow cytometry in the
different groups (control, sham 3 h, VNS 3 h). n = 10 rats per groups. *:
p,0.05. A significant decrease was observed for the VNS 3 h group
compared to the sham 3 h group for the isoflurane anesthetized rats.
No significant effect was observed for the pentobarbital anesthetized
rats.
doi:10.1371/journal.pone.0067086.g006
Figure 7. Quantification of tumor necrosis factor-a secreted by
cultured splenocytes for isoflurane and pentobarbital anes-
thetized rats. The concentration of tumor necrosis factor-a secreted
by cultured splenocytes isolated from isoflurane or pentobarbital
anesthetized rats was determined using the cytometric bead array
technique. ***: p,0.001. Different levels of TNF-a secretion were
observed depending on the anesthetic used. Regardless of the
conditions (control, sham 3 h or VNS 3 h) the level of TNF-a secretion
was significantly lower for the cultured splenocytes isolated from
isoflurane anesthetized groups compared to pentobarbital anesthetized
group.
doi:10.1371/journal.pone.0067086.g007
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